Stablecoin Development Corporation
Logotype for Stablecoin Development Corporation

Stablecoin Development Corporation (SDEV) investor relations material

Stablecoin Development Corporation Registration filing summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Stablecoin Development Corporation
Registration filing summary16 Nov, 2026

Company overview and business model

  • On-chain holding strategy targets long-duration participation in protocol-aligned digital asset ecosystems; SKY is the sole approved investment and is primarily held in native staking.

  • As of November 11, 2026, holdings were ~2.336 billion SKY, representing ~10% of total supply; the strategy may add assets meeting valuation, productivity, liquidity, quality, and risk criteria.

  • SKY staking supports protocol governance and earns rewards funded by Sky Protocol revenue and buybacks; holdings may be monetized for liquidity, tax, portfolio, or corporate purposes.

Financial performance and metrics

  • In 9M 2026, staking generated 101,701,388 SKY rewards and $6.8 million revenue; Q3 contributed 34,568,488 SKY and $2.1 million.

  • Published annualized SKY reward rates were 16.1% at December 31, 2025, 10.5% at March 31, 2026, 5.7% at June 30, 6.5% at September 30, and 4.7% at November 11, 2026.

  • As of September 30, 2026, ~$83.2 million remained available under the $100.0 million ATM program; acquisitions depend on market conditions, liquidity, and available cash.

Use of proceeds and capital allocation

  • Cash proceeds from warrant exercises, up to ~$8.1 million if all outstanding warrants are exercised for cash, are intended for general corporate purposes, including additional digital asset acquisitions.

  • No proceeds are expected from selling-stockholder resales; the selling stockholders bear their sale discounts and commissions, while registration expenses are borne by the registrant.

  • Capital allocation aims to acquire and hold select revenue-generating digital assets over multiple years, with substantially all excess cash directed to opportunistic SKY purchases.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Stablecoin Development Corporation earnings date

Logotype for Stablecoin Development Corporation
Q4 202625 Mar, 2027
Stablecoin Development Corporation
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Stablecoin Development Corporation earnings date

Logotype for Stablecoin Development Corporation
Q4 202625 Mar, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

NovaBay Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of innovative products for the eye care market. The company specializes in creating novel, fast-acting, synthetic anti-infectives designed to mimic the body’s natural defense mechanisms against infection. Its product portfolio includes solutions for eye care, such as Avenova, an antimicrobial lid and lash solution, as well as products for wound care and skincare. The company is headquartered in Emeryville, California, and its shares are listed on the NYSE.